Type of Dysmenorrhea, Menstrual Characteristics and Symptoms in Nursing Students in Southern Spain

Ana Abreu-Sánchez, María Laura Parra-Fernández, María Dolores Onieva-Zafra, Juan Diego Ramos-Pichardo, Elia Fernández-Martínez, Ana Abreu-Sánchez, María Laura Parra-Fernández, María Dolores Onieva-Zafra, Juan Diego Ramos-Pichardo, Elia Fernández-Martínez

Abstract

Dysmenorrhea is a form of chronic pain associated with menstruation that affects a high percentage of young people. This study sought to determine the prevalence of primary and secondary dysmenorrhea among female nursing students in southern Spain and to compare their menstrual characteristics and symptoms. A cross-sectional observational study was conducted using a self-report questionnaire that included sociodemographic variables, menstrual characteristics and related symptoms. Descriptive bivariate analysis and binary logistic regression were performed in which the dependent variable was secondary dysmenorrhea. The prevalence of dysmenorrhea was 73.8% (of which 63.3% had primary dysmenorrhea and 10.5% had secondary dysmenorrhea), and was more likely in women with longer periods, heavier bleeding and those not using oral hormonal contraception (OCP). Secondary dysmenorrhea was 31.75, (confidence interval (CI)95% = 4.44-238.59; p < 0.01) times more likely among those with menstrual headache, 8.37 (CI95% = 2.35-19.80; p < 0.01), times greater among those suffering nausea during menstruation, 6.60 (CI95% = 1.42-30.67; p < 0.01), times greater among those suffering from menstrual vomiting, it was also 1.17 (CI95% = 1.08-1.26; p < 0.01) times more likely for each day that the period was prolonged and 6.63 (CI95% = 1.47-30.01; p = 0.014) times more likely in women with a heavy menstrual flow. These findings may help guide professionals towards the prescription of additional tests in certain cases in which secondary dysmenorrhea is suspected.

Keywords: dysmenorrhea; menstrual pain; symptom.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Mihm M., Gangooly S., Muttukrishna S. The normal menstrual cycle in women. Anim. Reprod. Sci. 2011;124:229–236. doi: 10.1016/j.anireprosci.2010.08.030.
    1. Munro M.G. Classification of menstrual bleeding disorders. Rev. Endocr. Metab. Disord. 2012;13:225–234. doi: 10.1007/s11154-012-9220-x.
    1. Fernández-Martínez E., Onieva-Zafra M.D., Abreu-Sánchez A., Fernández-Muñóz J.J., Parra-Fernández M.L. Absenteeism during menstruation among nursing students in Spain. Int. J. Environ. Res. Public Health. 2020;17:53. doi: 10.3390/ijerph17010053.
    1. Armour M., Parry K., Manohar N., Holmes K., Ferfolja T., Curry C., MacMillan F., Smith C.A. The Prevalence and Academic Impact of Dysmenorrhea in 21,573 Young Women: A Systematic Review and Meta-Analysis. J. Women’s Health. 2019;28:1161–1171. doi: 10.1089/jwh.2018.7615.
    1. Akiyama S., Tanaka E., Cristeau O., Onishi Y., Osuga Y. Evaluation of the treatment patterns and economic burden of dysmenorrhea in japanese women, using a claims database. Clin. Outcomes Res. 2017;9:295–306. doi: 10.2147/CEOR.S127760.
    1. Matteson K.A., Zaluski K.M. Menstrual Health as a Part of Preventive Health Care. Obstet. Gynecol. Clin. N. Am. 2019;46:441–453. doi: 10.1016/j.ogc.2019.04.004.
    1. Harel Z. Dysmenorrhea in adolescents and young adults: An update on pharmacological treatments and management strategies. Expert Opin. Pharmacother. 2012;13:2157–2170. doi: 10.1517/14656566.2012.725045.
    1. Dawood M.Y. Dysmenorrhoea and Prostaglandins. Drugs. 1981;22:42–56. doi: 10.2165/00003495-198122010-00003.
    1. Iacovides S., Avidon I., Baker F.C. What we know about primary dysmenorrhea today: A critical review. Hum. Reprod. Update. 2015;21:762–778. doi: 10.1093/humupd/dmv039.
    1. Fajrin I., Alam G., Usman A.N. Prostaglandin level of primary dysmenorrhea pain sufferers. Enfermería Clin. 2020;30:5–9. doi: 10.1016/j.enfcli.2019.07.016.
    1. Strömberg P., Åkerlund M., Forsling M.L., Granström E., Kindahl H. Vasopressin and Prostaglandins in Premenstrual Pain and Primary Dysmenorrhea. Acta Obstet. Gynecol. Scand. 1984;63:533–538. doi: 10.3109/00016348409156715.
    1. Whitaker L.H.R., Reid J., Choa A., McFee S., Seretny M., Wilson J., Elton R.A., Vincent K., Horne A.W. An exploratory study into objective and reported characteristics of neuropathic pain in women with chronic pelvic pain. PLoS ONE. 2016;11:e0151950. doi: 10.1371/journal.pone.0151950.
    1. Janssen E.B., Rijkers A.C.M., Hoppenbrouwers K., Meuleman C., D’Hooghe T.M. Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: A systematic review. Hum. Reprod. Update. 2013;19:570–582. doi: 10.1093/humupd/dmt016.
    1. DiVasta A.D., Vitonis A.F., Laufer M.R., Missmer S.A. Spectrum of symptoms in women diagnosed with endometriosis during adolescence vs. adulthood. Am. J. Obstet. Gynecol. 2018;218:324.e1–324.e11. doi: 10.1016/j.ajog.2017.12.007.
    1. Osayande A.S., Mehulic S. Diagnosis and initial management of dysmenorrhea. Am. Fam. Physician. 2014;89:341–346.
    1. Proctor M., Farquhar C. Diagnosis and management of dysmenorrhoea. Br. Med. J. 2006;332:1134–1138. doi: 10.1136/bmj.332.7550.1134.
    1. Burnett M., Lemyre M. Primary Dysmenorrhea Consensus Guideline. J. Obstet. Gynaecol. Can. 2017;39:585–595. doi: 10.1016/j.jogc.2016.12.023.
    1. Chen C.X., Shieh C., Draucker C.B., Carpenter J.S. Reasons women do not seek health care for dysmenorrhea. J. Clin. Nurs. 2018;27:e301–e308. doi: 10.1111/jocn.13946.
    1. Fernández-Martínez E., Onieva-Zafra M.D., Parra-Fernández M.L. Lifestyle and prevalence of dysmenorrhea among Spanish female university students. PLoS ONE. 2018;13:e0201894. doi: 10.1371/journal.pone.0201894.
    1. Armour M., Smith C.A., Steel K.A., MacMillan F. The effectiveness of self-care and lifestyle interventions in primary dysmenorrhea: A systematic review and meta-analysis. BMC Complement. Altern. Med. 2019;19:22. doi: 10.1186/s12906-019-2433-8.
    1. Arakawa I., Momoeda M., Osuga Y., Ota I., Koga K. Cost-effectiveness of the recommended medical intervention for the treatment of dysmenorrhea and endometriosis in Japan. Cost Eff. Resour. Alloc. 2018;16:12. doi: 10.1186/s12962-018-0097-8.
    1. Gómez-Escalonilla Lorenzo B., Rodríguez Guardia Á., Marroyo Gordo J.M., Mozas Lillo R. de las Frecuencia y características de la dismenorrea en mujeres de la zona de salud de Torrijos (Toledo) Enfermería Clin. 2010;20:32–35. doi: 10.1016/j.enfcli.2009.09.001.
    1. Larroy C., Crespo M., Meseguer C. Dismenorrea Funcional en la Comunidad Autónoma de Madrid: Estudio de la Prevalencia en Función de la Edad. Rev. Soc. Esp. Dolor. 2001;8:11–22.
    1. Ortiz M.I. Primary dysmenorrhea among Mexican university students: Prevalence, impact and treatment. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010;152:73–77. doi: 10.1016/j.ejogrb.2010.04.015.
    1. Chen L., Tang L., Guo S., Kaminga A.C., Xu H. Primary dysmenorrhea and self-care strategies among Chinese college girls: A cross-sectional study. BMJ Open. 2019;9:e026813. doi: 10.1136/bmjopen-2018-026813.
    1. Hawker G.A., Mian S., Kendzerska T., French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF -36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP) Arthritis Care Res. 2011;63:S240–S252.
    1. Collins S.L., Moore R.A., McQuay H.J. The visual analogue pain intensity scale: What is moderate pain in millimetres? Pain. 1997;72:95–97. doi: 10.1016/S0304-3959(97)00005-5.
    1. Vlachou E., Owens D.A., Lavdaniti M., Kalemikerakis J., Evagelou E., Margari N., Fasoi G., Evangelidou E., Govina O., Tsartsalis A.N. Prevalence, Wellbeing, and Symptoms of Dysmenorrhea among University Nursing Students in Greece. Diseases. 2019;7:5. doi: 10.3390/diseases7010005.
    1. Söderman L., Edlund M., Marions L. Prevalence and impact of dysmenorrhea in Swedish adolescents. Acta Obstet. Gynecol. Scand. 2019;98:215–221. doi: 10.1111/aogs.13480.
    1. Rodrigues A.C., Gala S., Neves Â., Pinto C., Meirelles C., Frutuoso C., Vítor M.E. Dysmenorrhea in adolescents and young adults: Prevalence, related factors and limitations in daily living. Acta Med. Port. 2011;24(Suppl. 2):383–392.
    1. Bahrami A., Avan A., Sadeghnia H.R., Esmaeili H., Tayefi M., Ghasemi F., Nejati Salehkhani F., Arabpour-Dahoue M., Rastgar-Moghadam A., Ferns G.A., et al. High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents. Gynecol. Endocrinol. 2018;34:659–663. doi: 10.1080/09513590.2017.1423466.
    1. Bahrami A., Bahrami-Taghanaki H., Afkhamizadeh M., Avan A., Mazloum Khorasani Z., Esmaeili H., Amin B., Jazebi S., Kamali D., Ferns G.A., et al. Menstrual disorders and premenstrual symptoms in adolescents: Prevalence and relationship to serum calcium and vitamin D concentrations. J. Obstet. Gynaecol. 2018;38:989–995. doi: 10.1080/01443615.2018.1434764.
    1. Libarle M., Simon P., Bogne V., Pintiaux A., Furet E. Management of dysmenorrhea. Rev. Med. Brux. 2018;39:264–272.
    1. Ryan S.A. The Treatment of Dysmenorrhea. Pediatr. Clin. N. Am. 2017;64:331–342. doi: 10.1016/j.pcl.2016.11.004.
    1. Barcikowska Z., Rajkowska-Labon E., Grzybowska M.E., Hansdorfer-Korzon R., Zorena K. Inflammatory markers in dysmenorrhea and therapeutic options. Int. J. Environ. Res. Public Health. 2020;17:1191. doi: 10.3390/ijerph17041191.
    1. Vercellini P., Viganò P., Somigliana E., Fedele L. Endometriosis: Pathogenesis and treatment. Nat. Rev. Endocrinol. 2014;10:261–275. doi: 10.1038/nrendo.2013.255.
    1. Hu Z., Tang L., Chen L., Kaminga A.C., Xu H. Prevalence and Risk Factors Associated with Primary Dysmenorrhea among Chinese Female University Students: A Cross-sectional Study. J. Pediatr. Adolesc. Gynecol. 2020;33:15–22. doi: 10.1016/j.jpag.2019.09.004.
    1. Jenabi E. The effect of ginger for relieving of primary dysmenorrhoea. J. Pak. Med. Assoc. 2013;63:8–10.
    1. Ek M., Roth B., Ekström P., Valentin L., Bengtsson M., Ohlsson B. Gastrointestinal symptoms among endometriosis patients—A case-cohort study. BMC Womens Health. 2015;15:59. doi: 10.1186/s12905-015-0213-2.
    1. Evans S.F., Brooks T.A., Esterman A.J., Hull M.L., Rolan P.E. The comorbidities of dysmenorrhea: A clinical survey comparing symptom profile in women with and without endometriosis. J. Pain Res. 2018;11:3181–3194. doi: 10.2147/JPR.S179409.
    1. Teng S.W., Horng H.C., Ho C.H., Yen M.S., Chao H.T., Wang P.H., Chang Y.H., Chang Y., Chao K.C., Chen Y.J., et al. Women with endometriosis have higher comorbidities: Analysis of domestic data in Taiwan. J. Chin. Med. Assoc. 2016;79:577–582. doi: 10.1016/j.jcma.2016.04.006.
    1. Tietjen G.E., Conway A., Utley C., Gunning W.T., Herial N.A. Migraine is associated with menorrhagia and endometriosis. Headache. 2006;46:422–428. doi: 10.1111/j.1526-4610.2006.00290.x.
    1. Spierings E.L.H., Padamsee A. Menstrual-Cycle and Menstruation Disorders in Episodic vs. Chronic Migraine: An Exploratory Study. Pain Med. 2015;16:1426–1432. doi: 10.1111/pme.12788.
    1. Pakalnis A. Migraine and Hormones. Semin. Pediatr. Neurol. 2016;23:92–94. doi: 10.1016/j.spen.2016.01.005.
    1. Lieba-Samal D., Wöber C., Frantal S., Brannath W., Schmidt K., Schrolnberger C., Wöber-Bingöl Ç. Headache, menstruation and combined oral contraceptives: A diary study in 184 women with migraine. Eur. J. Pain. 2011;15:852–857. doi: 10.1016/j.ejpain.2011.02.003.
    1. Facchin F., Barbara G., Saita E., Mosconi P., Roberto A., Fedele L., Vercellini P. Impact of endometriosis on quality of life and mental health: Pelvic pain makes the difference. J. Psychosom. Obstet. Gynecol. 2015;36:135–141. doi: 10.3109/0167482X.2015.1074173.
    1. Speer L.M., Mushkbar S., Erbele T. Chronic Pelvic Pain in Women. Am. Fam. Physician. 2016;1:380–387.
    1. Greene A.D., Lang S.A., Kendziorski J.A., Sroga-Rios J.M., Herzog T.J., Burns K.A. Endometriosis: Where are we and where are we going? Reproduction. 2016;152:R63–R78. doi: 10.1530/REP-16-0052.
    1. Lundin C., Danielsson K.G., Bixo M., Moby L., Bengtsdotter H., Jawad I., Marions L., Brynhildsen J., Malmborg A., Lindh I., et al. Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle—A double-blind, placebo-controlled randomized trial. Psychoneuroendocrinology. 2017;76:135–143. doi: 10.1016/j.psyneuen.2016.11.033.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel